Cargando…

Kidney-type glutaminase is a biomarker for the diagnosis and prognosis of hepatocellular carcinoma: a prospective study

PURPOSE: The pathological diagnosis and prognosis prediction of hepatocellular carcinoma (HCC) is challenging due to the lack of specific biomarkers. This study aimed to validate the diagnostic and prognostic efficiency of Kidney-type glutaminase (GLS1) for HCC in prospective cohorts with a large sa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Laizhu, Su, Ke, Liu, Qi, Li, Binghua, Wang, Ye, Cheng, Chunxiao, Li, Yunzheng, Xu, Chun, Chen, Jun, Wu, Hongyan, Zhu, Mengxia, Mai, Xiaoli, Cao, Yajuan, Peng, Jin, Yue, Yang, Ding, Yitao, Yu, Decai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10633901/ https://www.ncbi.nlm.nih.gov/pubmed/37946141 http://dx.doi.org/10.1186/s12885-023-11601-y

Ejemplares similares

Combined clinical features and MRI parameters for the prediction of VEGFR2 in hepatocellular carcinoma patients
por: Zhang, Laizhu, et al.
Publicado: (2022)

Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma
por: Yu, Decai, et al.
Publicado: (2015)

Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt/beta-catenin pathway
por: Li, Binghua, et al.
Publicado: (2018)

Development and Validation of a Three-gene Prognostic Signature for Patients with Hepatocellular Carcinoma
por: Li, Binghua, et al.
Publicado: (2017)

Pan-Cancer Analysis of Glycolytic and Ketone Bodies Metabolic Genes: Implications for Response to Ketogenic Dietary Therapy
por: Qian, Liyuan, et al.
Publicado: (2021)

Paired assessment of liver telomere lengths in hepatocellular cancer is a reliable predictor of disease persistence
por: Feng, Wendu, et al.
Publicado: (2017)

Liver-enriched Genes are Associated with the Prognosis of Patients with Hepatocellular Carcinoma
por: Li, Binghua, et al.
Publicado: (2018)

Structural basis for exploring the allosteric inhibition of human kidney type glutaminase
por: Ramachandran, Sarath, et al.
Publicado: (2016)

Mitochondrial GCN5L1 regulates glutaminase acetylation and hepatocellular carcinoma
por: Zhang, Taotao, et al.
Publicado: (2022)

The inhibition of PARG attenuates DNA repair in hepatocellular carcinoma
por: Geng, Longpo, et al.
Publicado: (2023)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy
por: Lukey, Michael J., et al.
Publicado: (2016)

Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
por: Udupa, Sunag, et al.
Publicado: (2019)

Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome
por: Khoury, Elizabeth Smith, et al.
Publicado: (2020)

Nuclear factor-κB p65 regulates glutaminase 1 expression in human hepatocellular carcinoma
por: Dong, Meng, et al.
Publicado: (2018)

Q-ing tumor glutaminase therapy
por: Stine, Zachary E., et al.
Publicado: (2015)

Governing glutaminolysis by regulation of glutaminase succinylation
por: Ma, Qingxia, et al.
Publicado: (2021)

The Role of Glutamine and Glutaminase in Pulmonary Hypertension
por: Wang, Shang, et al.
Publicado: (2022)

Targeting glutaminase to starve lymphoma cells
por: Dumontet, Charles
Publicado: (2022)

Structural Basis for the Active Site Inhibition Mechanism of Human Kidney-Type Glutaminase (KGA)
por: Thangavelu, K., et al.
Publicado: (2014)

Kir4.2 mediates proximal potassium effects on glutaminase activity and kidney injury
por: Terker, Andrew S., et al.
Publicado: (2022)

The Glutaminase-1 Inhibitor 968 Enhances Dihydroartemisinin-Mediated Antitumor Efficacy in Hepatocellular Carcinoma Cells
por: Wang, Diancheng, et al.
Publicado: (2016)

Exosomal miR-665 as a novel minimally invasive biomarker for hepatocellular carcinoma diagnosis and prognosis
por: Qu, Zhen, et al.
Publicado: (2017)

Bioinformatic profiling identifies the glutaminase to be a potential novel cuproptosis-related biomarker for glioma
por: Ouyang, Zhen, et al.
Publicado: (2022)

Metabolic modulation of neurogenesis: Role of glutaminase-2
por: Salomoni, Paolo
Publicado: (2014)

Targeting hepatic glutaminase activity to ameliorate hyperglycemia
por: Miller, Russell A., et al.
Publicado: (2018)

Safety assessment of glutaminase from Aspergillus niger
por: Vo, Trung Duc, et al.
Publicado: (2020)

Glutaminase inhibition in renal cell carcinoma therapy
por: Raczka, Aleksandra M., et al.
Publicado: (2019)

Identification and characterization of a novel glutaminase inhibitor
por: Cederkvist, Henning, et al.
Publicado: (2021)

Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma
por: Yu, Decai, et al.
Publicado: (2007)

A natural inhibitor of kidney-type glutaminase: a withanolide from Physalis pubescens with potent anti-tumor activity
por: Wu, Canrong, et al.
Publicado: (2017)

BAG3 promotes autophagy and glutaminolysis via stabilizing glutaminase
por: Zhao, Song, et al.
Publicado: (2019)

Tumor-suppressive function of EZH2 is through inhibiting glutaminase
por: Liu, Yongfeng, et al.
Publicado: (2021)

Brucella abortus modulates macrophage polarization and inflammatory response by targeting glutaminases through the NF-κB signaling pathway
por: Zhao, Tianyi, et al.
Publicado: (2023)

Self-Assembled Micellar Glutaminase Allosteric Inhibitor for Effective Therapeutic Intervention
por: Fang, Jinzhang, et al.
Publicado: (2022)

Glutaminase Inhibition on NSCLC Depends on Extracellular Alanine Exploitation
por: Caiola, Elisa, et al.
Publicado: (2020)

Effect of glutaminase inhibition on cancer-induced bone pain
por: Fazzari, Jennifer, et al.
Publicado: (2019)

The Biological and Clinical Significance of Glutaminase in Luminal Breast Cancer
por: Masisi, Brendah K., et al.
Publicado: (2021)

Glutaminase 2 functions as a tumor suppressor gene in gastric cancer
por: Xu, Liang, et al.
Publicado: (2020)

Targeting glutaminase is therapeutically effective in ibrutinib-resistant mantle cell lymphoma
por: Li, Lingzhi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hds6uoejv160l11450m1k9n2oj